Tufts Silklab Created Leather-like Material from Silk Proteins
On May 5, 2021, researchers at Tufts University School of Engineering announced they had developed an alternative to…
-
-
The Priestley Medal was awarded to Paul Alivisatos
On Apr. 9, 2021, the American Chemical Society awarded The Priestley Medal to Paul Alivisatos “to recognize distinguished…
-
Merck Statement on Ivermectin use During the COVID-19 Pandemic
On Feb. 4, 2021, Merck affirmed its position regarding use of ivermectin during the COVID-19 pandemic, and do…
-
Zoetis Introducted Poulvac® Procerta™ HVT-IBD vaccine for infectious bursal disease
On Jan. 21, 2021, Zoetis announced it had as expanded its line of recombinant vector vaccines with the…
-
FDA approved Saxenda for the treatment of obesity in adolescents aged 12-17
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…
-
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine
NeuroRx and Relief announced successful results from expanded use of RLF-100 in patients with COVID-19
On Nov. 24, 2020, RELIEF THERAPEUTICS announced that more than 175 patients with Critical COVID-19 and Respiratory Failure…
-
Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…
-
Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
-
Disease | Therapeutics | WHO
No link between two ongoing Ebola outbreaks in the Democratic Republic of the Congo
On Jun. 9, 2020, new genetic sequence analysis by the Democratic Republic of the Congo’s (DRC) National Institute…
-
Eight US Manufacturers Selected to Make NASA COVID-19 Ventilator
On Mar. 25, 2020, NASA’s Jet Propulsion Laboratory (JPL) in Southern California announced that after receiving more than…
-
The Priestley Medal was awarded to JoAnne Stubbe
On Mar. 23 2020, The Priestley Medal was awarded to JoAnne Stubbe by the American Chemical Society “to…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine
Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
-
Researcher proved one of Darwin’s theories of evolution 140 years after his death
On Mar. 18, 2020, Laura van Holstein and and Robert A. Foley published “Terrestrial habitats decouple the relationship…
-
FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
-
Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
-
Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases
On Aug. 22, 2019, Chinook Therapeutics announced a $65 million Series A financing to discover and develop precision…
-
the largest stock of the rinderpest virus was destroyed at the Pirbright Institute.
On Jun. 14, 2019, the Pirbright Institute announced that it had destroyed the last samples of rinderpest virus…
-
U.S. FDA Approved Arctic® Fuji Apple
On May 2, 2019, the U.S. Food and Drug Authority (FDA) announced it had completed its voluntary review…
-
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
-
Genomic analysis offered insight into 2018 Nigeria Lassa fever outbreak
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
-
microbiota vault Project Established
On Oct. 5, 2018, the rationale around the Microbiome Vault initiative was published in Science. The initiative was…
-
AbCellera raises $10M for machine-learning fueled antibody discovery platform
On Sept. 27, 2018, AbCellera, a biotech startup based in Vancouver, B.C., announced that it has raised a…
-
Golden Rice Approved by U.S. FDA
On May 24, 2018, the United States Food and Drug Administration (U.S. FDA) released a statement on GR2E…
-
WHO recommended use of first typhoid conjugate vaccine
On Apr. 3, 2018, the World Health Organization (WHO) recommended the introduction of typhoid conjugate vaccine (TCV) for…
-
Scientists Sequenced Genome of Axolotl
On Jan. 24, 2018, a team of researchers led by scientists in Vienna, Dresden and Heidelberg announced they…
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Influenza | U.S. Congress | Vaccine | Veterinary
Experts decried lack of flu pandemic readiness, commitment
On Jan. 9, 2018, armed with 1940s-vintage flu vaccine technology and supported by only anemic funding for developing…
-
Scientists Created First Semi-Synthetic Organism that Stored and Retrieved Unnatural Information
On Nov. 29, 2017, scientists at The Scripps Research Institute (TSRI) announced they had designed a bacterium with…
-
Screwworm eradicated in Florida, again
On April 26, 2017, the U.S. Department of Agriculture’s (USDA) announced that the New World screwworm (NWS) had…
-
Some 300 million people suffer from depression worldwide
On Mar. 31, 2017, more than 300 million people are now living with depression, which is the leading…
-
Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
